María Inés Pinto-Sánchez1, Natalia Causada-Calo1, Premysl Bercik1, Alexander C Ford2, Joseph A Murray3, David Armstrong1, Carol Semrad4, Sonia S Kupfer4, Armin Alaedini5, Paul Moayyedi1, Daniel A Leffler6, Elena F Verdú7, Peter Green5. 1. Department of Medicine, Farncombe Family Digestive Research Institute, McMaster University, Hamilton, Ontario, Canada. 2. Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, United Kingdom; Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, United Kingdom. 3. Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. 4. Celiac Disease Center at University of Chicago Medicine, Chicago, Illinois. 5. Celiac Disease Center at Columbia University, New York, New York. 6. Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, Massachusetts. 7. Department of Medicine, Farncombe Family Digestive Research Institute, McMaster University, Hamilton, Ontario, Canada. Electronic address: verdue@mcmaster.ca.
Abstract
BACKGROUND & AIMS: Patients with celiac disease should maintain a gluten-free diet (GFD), excluding wheat, rye, and barley. Oats might increase the nutritional value of a GFD, but their inclusion is controversial. We performed a systematic review and meta-analysis to evaluate the safety of oats as part of a GFD in patients with celiac disease. METHODS: We searched the Cochrane Central Register of Controlled Trials, MEDLINE, and EMBASE databases for clinical trials and observational studies of the effects of including oats in GFD of patients with celiac disease. The studies reported patients' symptoms, results from serology tests, and findings from histologic analyses. We used the GRADE approach to assess the quality of evidence. RESULTS: We identified 433 studies; 28 were eligible for analysis. Of these, 6 were randomized and 2 were not randomized controlled trials comprising a total of 661 patients-the remaining studies were observational. All randomized controlled trials used pure/uncontaminated oats. Oat consumption for 12 months did not affect symptoms (standardized mean difference: reduction in symptom scores in patients who did and did not consume oats, -0.22; 95% CI, -0.56 to 0.13; P = .22), histologic scores (relative risk for histologic findings in patients who consumed oats, 0.24; 95% CI, 0.01-4.8; P = .35), intraepithelial lymphocyte counts (standardized mean difference, 0.21; 95% CI, reduction of 1.44 to increase in 1.86), or results from serologic tests. Subgroup analyses of adults vs children did not reveal differences. The overall quality of evidence was low. CONCLUSIONS: In a systematic review and meta-analysis, we found no evidence that addition of oats to a GFD affects symptoms, histology, immunity, or serologic features of patients with celiac disease. However, there were few studies for many endpoints, as well as limited geographic distribution and low quality of evidence. Rigorous double-blind, placebo-controlled, randomized controlled trials, using commonly available oats sourced from different regions, are needed.
BACKGROUND & AIMS:Patients with celiac disease should maintain a gluten-free diet (GFD), excluding wheat, rye, and barley. Oats might increase the nutritional value of a GFD, but their inclusion is controversial. We performed a systematic review and meta-analysis to evaluate the safety of oats as part of a GFD in patients with celiac disease. METHODS: We searched the Cochrane Central Register of Controlled Trials, MEDLINE, and EMBASE databases for clinical trials and observational studies of the effects of including oats in GFD of patients with celiac disease. The studies reported patients' symptoms, results from serology tests, and findings from histologic analyses. We used the GRADE approach to assess the quality of evidence. RESULTS: We identified 433 studies; 28 were eligible for analysis. Of these, 6 were randomized and 2 were not randomized controlled trials comprising a total of 661 patients-the remaining studies were observational. All randomized controlled trials used pure/uncontaminated oats. Oat consumption for 12 months did not affect symptoms (standardized mean difference: reduction in symptom scores in patients who did and did not consume oats, -0.22; 95% CI, -0.56 to 0.13; P = .22), histologic scores (relative risk for histologic findings in patients who consumed oats, 0.24; 95% CI, 0.01-4.8; P = .35), intraepithelial lymphocyte counts (standardized mean difference, 0.21; 95% CI, reduction of 1.44 to increase in 1.86), or results from serologic tests. Subgroup analyses of adults vs children did not reveal differences. The overall quality of evidence was low. CONCLUSIONS: In a systematic review and meta-analysis, we found no evidence that addition of oats to a GFD affects symptoms, histology, immunity, or serologic features of patients with celiac disease. However, there were few studies for many endpoints, as well as limited geographic distribution and low quality of evidence. Rigorous double-blind, placebo-controlled, randomized controlled trials, using commonly available oats sourced from different regions, are needed.
Authors: Karl Mårild; Fran Dong; Nicolai A Lund-Blix; Jennifer Seifert; Anna E Barón; Kathleen C Waugh; Iman Taki; Ketil Størdal; German Tapia; Lars C Stene; Randi K Johnson; Edwin Liu; Marian J Rewers; Jill M Norris Journal: Am J Gastroenterol Date: 2019-08 Impact factor: 10.864
Authors: Nadia Kamal; Nikos Tsardakas Renhuldt; Johan Bentzer; Heidrun Gundlach; Georg Haberer; Angéla Juhász; Thomas Lux; Utpal Bose; Jason A Tye-Din; Daniel Lang; Nico van Gessel; Ralf Reski; Yong-Bi Fu; Peter Spégel; Alf Ceplitis; Axel Himmelbach; Amanda J Waters; Wubishet A Bekele; Michelle L Colgrave; Mats Hansson; Nils Stein; Klaus F X Mayer; Eric N Jellen; Peter J Maughan; Nicholas A Tinker; Martin Mascher; Olof Olsson; Manuel Spannagl; Nick Sirijovski Journal: Nature Date: 2022-05-18 Impact factor: 69.504
Authors: Plaimein Amnuaycheewa; Mohamed Abdelmoteleb; John Wise; Barbara Bohle; Fatima Ferreira; Afua O Tetteh; Steve L Taylor; Richard E Goodman Journal: Front Allergy Date: 2022-05-26
Authors: Greg Tanner; Angéla Juhász; Christakis George Florides; Mitchell Nye-Wood; Frank Békés; Michelle L Colgrave; Amy K Russell; Melinda Y Hardy; Jason A Tye-Din Journal: Front Nutr Date: 2019-10-15